The goal of the University of Michigan WRHR Program is to Fast Forward the effectiveness of obstetrician/gynecologist scientists through a department-based, multidisciplinary junior faculty development program. We plan to capitalize on the research investments and expertise of the University of Michigan and train junior faculty in research areas most likely to lead to significant breakthroughs in women's health. We selected research areas and mentors based on Department and Institutional research priorities and strengths. From among the potential mentors in the Department's Reproductive Sciences Program, Pelvic Floor Program, and the University of Michigan's Fast Forward Initiative, we have chosen those with proven records of accomplishment in fostering the development of junior faculty researchers. The research programs of these mentors span cutting-edge reproductive biology, pelvic floor medicine, metabolomics, oncology, protein folding diseases, sleep disorders, microbiome, and genetics. We propose to recruit obstetrics/gynecology faculty to develop their women's reproductive health research careers for a minimum of two and up to five years. During the past five years, we have developed a track record of training outstanding WRHR scholars with unique research niches. It is our goal to select the most promising candidates for appointment from three year ACOG approved subspecialty fellowships as well as Minimally Invasive Surgery, Family Planning, Genetics, Pediatric and Adolescent Gynecology, Breast, and Women's Health fellowships, American Gynecological and Obstetrical Society fellows, and Robert Wood Johnson Clinical Scholar programs to participate in the WRHR. Proven medical school-wide programs are in place to recruit and support underrepresented minority scholars. A Career Development Program and Center Advisory Committee will assure that the scholars have the best possible environment for success. The PI and Research Director will ensure regular and timely assessments and feedback from the scholars and mentors. The program will be measured by the success of WRHR scholars achieving research independence and in receiving extramural funding.

Public Health Relevance

Women's reproductive research is critically important to improving the health of Americans. Scientific advances in reproductive biology, gynecologic cancer biology, pelvic floor disorders, sleep disorders, genetics, microbiome, metabolomics, and protein folding diseases have potential to substantially impact women nationally, especially underserved and minority women.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Physician Scientist Award (Program) (PSA) (K12)
Project #
2K12HD065257-06
Application #
8990262
Study Section
Special Emphasis Panel (ZHD1-DSR-L (50))
Program Officer
Halvorson, Lisa M
Project Start
2010-04-01
Project End
2020-06-30
Budget Start
2015-07-18
Budget End
2016-06-30
Support Year
6
Fiscal Year
2015
Total Cost
$333,714
Indirect Cost
$25,174
Name
University of Michigan Ann Arbor
Department
Obstetrics & Gynecology
Type
Schools of Medicine
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Sammarco, Anne G; Swenson, Carolyn W; Kamdar, Neil S et al. (2018) Rate of Pelvic Organ Prolapse Surgery Among Privately Insured Women in the United States, 2010-2013. Obstet Gynecol 131:484-492
Swenson, Carolyn W; DePorre, Julia A; Haefner, Jessica K et al. (2018) Postpartum depression screening and pelvic floor symptoms among women referred to a specialty postpartum perineal clinic. Am J Obstet Gynecol 218:335.e1-335.e6
McLean, Karen; Tan, Lijun; Bolland, Danielle E et al. (2018) Leukemia inhibitory factor functions in parallel with interleukin-6 to promote ovarian cancer growth. Oncogene :
Swenson, Carolyn W; Morgan, Daniel M; George, Jenny et al. (2018) Effect of Cystocele Repair on Cervix Location in Women With Uterus In Situ. Female Pelvic Med Reconstr Surg 24:56-59
Schmidt, Payton; Berger, Mitchell B; Day, Lori et al. (2018) Home opioid use following cesarean delivery: How many opioid tablets should obstetricians prescribe? J Obstet Gynaecol Res 44:723-729
Morgan, Daniel M; Kamdar, Neil S; Swenson, Carolyn W et al. (2018) Nationwide trends in the utilization of and payments for hysterectomy in the United States among commercially insured women. Am J Obstet Gynecol 218:425.e1-425.e18
Schon, Samantha B; Shapiro, Maren; Gracia, Clarisa et al. (2017) Medical and elective fertility preservation: impact of removal of the experimental label from oocyte cryopreservation. J Assist Reprod Genet 34:1207-1215
Sammarco, Anne G; Nandikanti, Lahari; Kobernik, Emily K et al. (2017) Interactions among pelvic organ protrusion, levator ani descent, and hiatal enlargement in women with and without prolapse. Am J Obstet Gynecol 217:614.e1-614.e7
Harris, John A; Sammarco, Anne G; Swenson, Carolyn W et al. (2017) Are perioperative bundles associated with reduced postoperative morbidity in women undergoing benign hysterectomy? Retrospective cohort analysis of 16,286 cases in Michigan. Am J Obstet Gynecol 216:502.e1-502.e11
Chai, Daniel; Bassis, Christine M; Bergin, Ingrid L et al. (2017) Prevalence and geographical distribution of Papio hamadryas papillomavirus 1 (PhPV1) in Kenyan baboons. J Med Primatol 46:13-15

Showing the most recent 10 out of 29 publications